Invasive carcinoma of breast
Item
patients with histological diagnosis of invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Early-Stage Breast Carcinoma Resectable TNM clinical staging | Complete excision Possible
Item
patients with early stage i, ii,iii breast cancer amendable for complete surgical resection.
boolean
C2986665 (UMLS CUI [1,1])
C1514888 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0015250 (UMLS CUI [2,1])
C0332149 (UMLS CUI [2,2])
Nodal status Any
Item
patients with any nodal status
boolean
C0449927 (UMLS CUI [1,1])
C1552551 (UMLS CUI [1,2])
Estrogen receptor negative neoplasm | Progesterone receptor negative neoplasm | Axillary Lymph Node Involvement Hormone Receptor Any
Item
patients with er and pr -negative tumors. in case of axillary involvement:any hormonal receptors status.
boolean
C2584629 (UMLS CUI [1])
C2584628 (UMLS CUI [2])
C0741343 (UMLS CUI [3,1])
C0019929 (UMLS CUI [3,2])
C1552551 (UMLS CUI [3,3])
ECOG performance status
Item
perfomance status 0-1 on the ecog scale
boolean
C1520224 (UMLS CUI [1])
Indication Adjuvant Chemotherapy
Item
patients indicated for adjuvant chemotherapy
boolean
C3146298 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
Chemotherapy | Therapeutic radiology procedure
Item
no previous chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Operative Surgical Procedure | Chemotherapy
Item
patients have to be randomized within 8 weeks after surgery. its recommended that patients will start chemotherapy within 1 month after surgical treatment.
boolean
C0543467 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy/breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic disease Serious
Item
serious concomitant systemic disorders incompatible with the study
boolean
C0442893 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Neoplasms, Second Primary | Carcinoma in situ of uterine cervix | Basal cell carcinoma Treated
Item
second primary malignancy (expect in situ carcinoma of the cervix or adequately treated basal cell carcinoma of the skin)
boolean
C0085183 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0007117 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
Investigational New Drugs
Item
use of any other investigational agent within 4 weeks before enrollment into the study
boolean
C0013230 (UMLS CUI [1])
Therapeutic radiology procedure | Chemotherapy | Hormone Therapy | Immunotherapy
Item
cocurrent administration of radiation therapy, chemotherapy, hormonal therapy or immunotherapy
boolean
C1522449 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0021083 (UMLS CUI [4])